Results 101 to 110 of about 28,868 (173)

Point-of-care Tests for Chlamydia trachomatis and Neisseria gonorrhoeae: Review of the Literature. [PDF]

Clin Infect Dis
Manabe YC, Smith AC, Trow S, Tran A, Van Der Pol B.   +4 more
europepmc   +1 more source

Plasmids in <i>Neisseria gonorrhoeae</i>: drivers of DoxyPEP failure and an emerging threat for current therapy. [PDF]

Clin Microbiol Rev
Elsener TA, Dillon J-AR, Shafer WM, Tang CM.   +3 more
europepmc   +1 more source

Tetracycline Resistance Among Neisseria gonorrhoeae Isolates-United States, 1987-2022. [PDF]

Sex Transm Dis
Wondmeneh S, Learner ER, Schmerer MW, Harvey A, Mauk K, Papp JR, Quilter LAS, St Cyr SB, Antimicrobial-Resistant Neisseria gonorrhoeae Working Group.   +8 more
europepmc   +1 more source

First Study on Antimicrobial Susceptibility and Molecular Epidemiology of <i>Neisseria gonorrhoeae</i> Isolates from Infertile Women. [PDF]

Infect Drug Resist
Huang Y, Hu J, Ji H, He X, Liu J, Wu T, Wang J, Liu G.   +7 more
europepmc   +1 more source

Treatment Diversification to Address the Continued Rise of Antimicrobial Resistance in Neisseria gonorrhoeae. [PDF]

Clin Infect Dis
Allan-Blitz LT, Klausner JD.
europepmc   +1 more source

Prevalence and epidemiological patterns of Neisseria gonorrhoeae infection in sub-Saharan Africa, 1964-2025: Systematic review, meta-analyses, and meta-regressions. [PDF]

PLoS Med
Osman A, Akram H, Alemrayat B, Al-Maraghi S, Harfouche M, Abu-Raddad LJ.   +5 more
europepmc   +1 more source

Fatty acids-based compounds as novel prophylaxis or treatment for oropharyngeal <i>Neisseria gonorrhoeae:</i> an <i>in vitro</i> study. [PDF]

Emerg Microbes Infect
Hamza SA, Paolini R, Moore C, Unemo M, Yap T, McCullough M, Mayfosh A, Rau T, Kleid S, Hocking JS, Kong FY, Celentano A.   +11 more
europepmc   +1 more source

Prevalence and epidemiological patterns of Neisseria gonorrhoeae infection in Canada, 1969-2025: a systematic review and meta-analysis. [PDF]

BMC Public Health
Harfouche M, Khan A, Taha A, El-Khoury R, Ageeb RA, Abu-Raddad LJ.   +5 more
europepmc   +1 more source

Evaluation of the surface lipoprotein assembly modifier (Slam) as a vaccine candidate against Neisseria gonorrhoeae infection. [PDF]

Sci Rep
He Y, Huang Y, Dong F, Wang W, Zhang L, Zhang L.   +5 more
europepmc   +1 more source

Identification of the cannabinoid receptor 1 antagonist, ibipinabant, as a potent inhibitor of <i>Neisseria gonorrhoeae</i>. [PDF]

Antimicrob Agents Chemother
Dove AS, Abdelsattar AS, Abutaleb NS, Seleem MN.   +3 more
europepmc   +1 more source